Akoya Biosciences, Inc. (AKYA)
USD 2.45
(-3.54%)
USD 2.45
(-3.54%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 56.3 Million USD | 11.17% |
| 2022 | 43.39 Million USD | 26.8% |
| 2021 | 34.21 Million USD | 32.08% |
| 2020 | 25.9 Million USD | 5.05% |
| 2019 | 24.66 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 13.38 Million USD | 59.76% |
| 2024 Q1 | 8.37 Million USD | -43.18% |
| 2023 Q4 | 14.74 Million USD | -3.47% |
| 2023 FY | 48.23 Million USD | 11.17% |
| 2023 Q3 | 15.27 Million USD | 26.08% |
| 2023 Q2 | 12.11 Million USD | -1.44% |
| 2023 Q1 | 12.29 Million USD | 2.05% |
| 2022 Q2 | 10.34 Million USD | 2.43% |
| 2022 Q1 | 10.09 Million USD | -1.27% |
| 2022 FY | 43.39 Million USD | 26.8% |
| 2022 Q4 | 12.04 Million USD | 10.44% |
| 2022 Q3 | 10.9 Million USD | 5.47% |
| 2021 Q1 | 7.4 Million USD | -6.36% |
| 2021 FY | 34.21 Million USD | 32.08% |
| 2021 Q4 | 10.22 Million USD | 20.97% |
| 2021 Q3 | 8.45 Million USD | 3.92% |
| 2021 Q2 | 8.13 Million USD | 9.84% |
| 2020 FY | 25.9 Million USD | 5.05% |
| 2020 Q4 | 7.9 Million USD | 31.06% |
| 2020 Q3 | 6.03 Million USD | 14.5% |
| 2020 Q2 | 5.27 Million USD | -21.3% |
| 2020 Q1 | 6.69 Million USD | 0.0% |
| 2019 FY | 24.66 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AngioDynamics, Inc. | 154.69 Million USD | 63.603% |
| AtriCure, Inc. | 300.37 Million USD | 81.255% |
| Avinger, Inc. | 2 Million USD | -2711.033% |
| Azenta, Inc. | 263.14 Million USD | 78.603% |
| BioLife Solutions, Inc. | 46.75 Million USD | -20.433% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 97.612% |
| Daxor Corporation | 1.1 Million USD | -5002.679% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -520.167% |
| Femasys Inc. | 691.9 Thousand USD | -8037.725% |
| GlucoTrack, Inc. | -13 Thousand USD | 433215.385% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 7.494% |
| Hologic, Inc. | 2.22 Billion USD | 97.473% |
| ICU Medical, Inc. | 739.87 Million USD | 92.39% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 98.809% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -236.989% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 55.682% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 47284.674% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 47284.674% |
| Masimo Corporation | 1 Billion USD | 94.389% |
| Microbot Medical Inc. | -106 Thousand USD | 53217.925% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -70.131% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 90.357% |
| Nephros, Inc. | 8.4 Million USD | -569.899% |
| NovoCure Limited | 381.05 Million USD | 85.224% |
| NEXGEL, Inc. | 619 Thousand USD | -8996.123% |
| NEXGEL, Inc. | 619 Thousand USD | -8996.123% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 10190.502% |
| OraSure Technologies, Inc. | 179.42 Million USD | 68.619% |
| Pro-Dex, Inc. | 14.55 Million USD | -286.949% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 4764.872% |
| Predictive Oncology Inc. | 1.14 Million USD | -4816.192% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -871.148% |
| QuidelOrtho Corporation | 1.49 Billion USD | 96.232% |
| Repligen Corporation | 315.22 Million USD | 82.138% |
| Sanara MedTech Inc. | 57.13 Million USD | 1.456% |
| STAAR Surgical Company | 252.65 Million USD | 77.714% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 6417.546% |
| Utah Medical Products, Inc. | 30.03 Million USD | -87.446% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 97.301% |
| Jin Medical International Ltd. | 6.78 Million USD | -729.866% |